Press release
September 16, 2015
New Documentary Released by Corindus Vascular Robotics Demonstrates How Back Injuries Risk Physician Careers

"Robotics Reducing the Burden of a Life in the Cath Lab" highlights noted interventional cardiologist Dr. Vijay Iyer to show how Corindus' robotic technology may reduce the risk of further injuries.

WALTHAM, MA, September 16, 2015 Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, has released a new documentary film, "Robotics Reducing the Burden of a Life in the Cath Lab," to highlight the impact that protective lead apparel has on physicians practicing in catheterization labs and how robotics are employed to help solve these problems. The documentary features noted interventional cardiologist Dr. Vijay S. Iyer, who serves as Medical Director of Structural Heart Interventions at Gates Vascular Institute, Kaleida Health, in Buffalo, N.Y.

Dr. Iyer credits the CorPath® System with providing an alternative solution to constantly wearing heavy lead apparel to protect him from radiation. The CorPath System is the first and only FDA-cleared device for robotic-assisted PCI. The CorPath System protects interventional cardiologists from occupational radiation exposure and brings robotic-assisted precision to coronary angioplasty procedures.

"The radiation that comes from the X-ray machine is a constant threat to us, but by wearing the lead to protect myself, I ended up with serious back injuries," said Dr. Iyer. "My most recent surgery kept me out of work for six weeks, and many patients waited to have their procedure until I returned. I knew if the stress on my spine continued, the injury could put an end to my career as an interventional cardiologist."

Dr. Iyer has experienced multiple spinal disc herniations and has had four surgeries as a result of continual stresses on his musculoskeletal system from wearing traditional heavy, lead-lined apparel in the cath lab. Physicians wear the gear to protect themselves from the constant exposure to ionizing radiation during procedures in cath labs. Interventional cardiologists often perform multiple procedures each day, standing for hours, leaning over their patients while wearing a significant amount of weight, which can lead to musculoskeletal and orthopedic injuries.

"The CorPath System allows me to step away from the patient table, take my lead off, and sit down at a radiation shielded workstation where I have robotic control of the wire, balloon and stent," explained Dr. Iyer. "I'm no longer going to work every day dreading that back injury could make it the last day I'm an interventional cardiologist."

For Dr. Iyer, the CorPath System has offered him a chance to continue doing the work he enjoys without the stress and strain of heavy protective equipment that exacerbates his back problems. Musculoskeletal injuries such as Dr. Iyer's represent one type of occupational health risk linked to radiation exposure in the cath lab. Others potential risks that have been documented include cataracts, cancer, brain tumors, and thyroid diseases.

"Dr. Iyer's story highlights the serious risks linked to occupational radiation exposure in the cath lab that, if ignored, may cost many interventional cardiologists their health and careers," said David Handler, President and CEO of Corindus. "Hospital leadership and administrators need to leverage the technology now available to create a work environment for physicians to preserve their health and perform their jobs safely and effectively. The CorPath System offers unique advantages of protection and robotic precision for PCI procedures."

The complete video can be accessed at's-story/. For more information about the CorPath System, visit

About Corindus Vascular Robotics, Inc.

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company's CorPath System is the first FDA-cleared medical device to bring robotic precision to interventional procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance guide catheters, stents, and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement during manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program."

For additional information, visit, and follow @CorindusInc.

Forward Looking Statements

Statements made in this release that are not statements of historical or current facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Corindus to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements in the conditional or future tenses or that includes terms such as "believes," "belief," "expects," "estimates," "intends," "anticipates" or "plans" to be uncertain and forward-looking. Forward-looking statements may include comments as to Corindus’ beliefs and expectations as to future event

Examples of such statements include statements:

  • that the level of precision that can be attained using the CorPath GRX technology, combined with the potential for remote capabilities in the future, will both expand and improve how patients are treated;
  • that Corindus has entered a transformational period with a focus on expanding its reach to partner with hospitals to build robotic programs globally;
  • that the successful completion of these procedures at Fu Wai Hospital is the first step in Corindus' growth strategy within China; and that
  • the precise positioning enhancements to the CorPath platform that allows physicians to adjust guide catheters during PCI procedures may expand the use of the CorPath GRX System to more complex cases.

Media Contacts:

Corindus Vascular Robotics, Inc.

Kate Stanton
(508) 653-3335 ext. 200

Investor Contact:

Lynn Pieper Lewis
(415) 937-5402
close the window

Please complete the form below in order to download the content.

close the window

Please complete the form below in order to download the content.

close the window

Please fill out this brief form to subscribe to our email newsletter. By submitting this form, I consent to receive email communications from Corindus.

close the window

Please complete the form below and a member of our Clinical team will contact you.

close the window

Please complete the form below in order to download the content.

close the window

The page you wish to view contains content that is not available in all regions. Please select your region.

close the window